THAÇI, D.; ARMSTRONG, A.; GORDON, K. B.; BLAUVELT, A.; PAUL, C.; BOEHNCKE, W.-H.; WANG, M.; SZILAGYI, B. .; HOEPKEN, B.; LAMBERT, J.; LEBWOHL, M. Bimekizumab 3-year Maintenance of Response in Week 16 Responders with Moderate to Severe Plaque Psoriasis: Results from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s306, 2024. DOI: 10.25251/skin.8.supp.306. Disponível em: https://jofskin.org/index.php/skin/article/view/2452. Acesso em: 19 jul. 2024.